scispace - formally typeset
P

Pietro Tiraboschi

Researcher at Carlo Besta Neurological Institute

Publications -  100
Citations -  6786

Pietro Tiraboschi is an academic researcher from Carlo Besta Neurological Institute. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 26, co-authored 63 publications receiving 5087 citations. Previous affiliations of Pietro Tiraboschi include University of Chieti-Pescara & University of Cambridge.

Papers
More filters
Journal ArticleDOI

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.

Sofia Bergström, +151 more
TL;DR: In this paper, a multiplexed antibody-based suspension bead array was used to analyse levels of 111 proteins in CSF samples from 221 individuals from families with genetic frontotemporal dementia.
Journal ArticleDOI

Postinfectious Neurologic Complications in COVID-19: A Complex Case Report.

TL;DR: In this article, a 40-year-old woman with severe acute respiratory syndrome coronavirus 2 infection developed neurologic manifestations (confusion, agitation, seizures, dyskinesias, and parkinsonism) a few weeks after the onset of SRS.
Journal ArticleDOI

Disease-related cortical thinning in presymptomatic granulin mutation carriers.

Sergi Borrego-Écija, +130 more
- 01 Jan 2021 - 
TL;DR: In this paper, the authors analyzed 3T MRI structural images using the FreeSurfer pipeline to calculate the whole brain cortical thickness (CTh) for each subject and performed a vertex-wise general linear model to assess differences between groups in the relationship between CTh and diverse covariables such as gender, age, the estimated years to onset and education.
Journal ArticleDOI

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Emma L. van der Ende, +145 more
TL;DR: In this paper , the value of complement proteins, which are key components of innate immunity, as biomarkers in cerebrospinal fluid (CSF) and plasma of presymptomatic and symptomatic genetic FTD mutation carriers was determined.
Journal ArticleDOI

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Emma L. van der Ende, +145 more
TL;DR: In this paper , the value of complement proteins, which are key components of innate immunity, as biomarkers in cerebrospinal fluid (CSF) and plasma of presymptomatic and symptomatic genetic FTD mutation carriers was determined.